Cancer survival in Incheon, Republic of Korea, 1997-2001.

Z. H. Woo, Yun-Chul Hong, W. C. Kim, Y. K. Pu

Research output: Contribution to journalArticleResearchpeer-review

4 Citations (Scopus)

Abstract

The Incheon cancer registry was established in 1997. Cancer is not a notifiable disease, hence registration of cases is done by active methods. The registry contributed survival data for 42 cancer sites or types registered during 1997-2001. The follow-up information has been obtained predominantly by passive methods, with median follow-up ranging between 1-44 months for various cancers. The proportion with histologically verified diagnosis for different cancers ranged between 16-100%; death certificates only (DCOs) comprised 0-51%; 49-100% of total registered cases were included for the survival analysis. The top-ranking cancers on 5-year age-standardized relative survival rates were testis (98%), thyroid (90%), ureter (87%), adrenal gland (86%), nonmelanoma skin (83%), corpus uteri (82%), Hodgkin lymphoma (81%), breast and cervix (74%). Five-year relative survival by age group showed a decreasing trend with increasing age groups for cancers of the stomach, small intestine, colon, gall bladder, larynx, lung, breast, cervix and ovary, and was fluctuating for other cancers.

Original languageEnglish
Pages (from-to)163-169
Number of pages7
JournalIARC scientific publications
Issue number162
StatePublished - 5 Jul 2011

Fingerprint

Republic of Korea
Survival
Neoplasms
Cervix Uteri
Registries
Breast
Age Groups
Death Certificates
Ureter
Survival Analysis
Larynx
Adrenal Glands
Hodgkin Disease
Small Intestine
Stomach Neoplasms
Uterus
Testis
Ovary
Thyroid Gland
Colon

Cite this

Woo, Z. H. ; Hong, Yun-Chul ; Kim, W. C. ; Pu, Y. K. / Cancer survival in Incheon, Republic of Korea, 1997-2001. In: IARC scientific publications. 2011 ; No. 162. pp. 163-169.
@article{8453b5359bd04178a7d7a1c8e74ae33d,
title = "Cancer survival in Incheon, Republic of Korea, 1997-2001.",
abstract = "The Incheon cancer registry was established in 1997. Cancer is not a notifiable disease, hence registration of cases is done by active methods. The registry contributed survival data for 42 cancer sites or types registered during 1997-2001. The follow-up information has been obtained predominantly by passive methods, with median follow-up ranging between 1-44 months for various cancers. The proportion with histologically verified diagnosis for different cancers ranged between 16-100{\%}; death certificates only (DCOs) comprised 0-51{\%}; 49-100{\%} of total registered cases were included for the survival analysis. The top-ranking cancers on 5-year age-standardized relative survival rates were testis (98{\%}), thyroid (90{\%}), ureter (87{\%}), adrenal gland (86{\%}), nonmelanoma skin (83{\%}), corpus uteri (82{\%}), Hodgkin lymphoma (81{\%}), breast and cervix (74{\%}). Five-year relative survival by age group showed a decreasing trend with increasing age groups for cancers of the stomach, small intestine, colon, gall bladder, larynx, lung, breast, cervix and ovary, and was fluctuating for other cancers.",
author = "Woo, {Z. H.} and Yun-Chul Hong and Kim, {W. C.} and Pu, {Y. K.}",
year = "2011",
month = "7",
day = "5",
language = "English",
pages = "163--169",
journal = "IARC scientific publications",
issn = "0300-5038",
publisher = "IARC",
number = "162",

}

Cancer survival in Incheon, Republic of Korea, 1997-2001. / Woo, Z. H.; Hong, Yun-Chul; Kim, W. C.; Pu, Y. K.

In: IARC scientific publications, No. 162, 05.07.2011, p. 163-169.

Research output: Contribution to journalArticleResearchpeer-review

TY - JOUR

T1 - Cancer survival in Incheon, Republic of Korea, 1997-2001.

AU - Woo, Z. H.

AU - Hong, Yun-Chul

AU - Kim, W. C.

AU - Pu, Y. K.

PY - 2011/7/5

Y1 - 2011/7/5

N2 - The Incheon cancer registry was established in 1997. Cancer is not a notifiable disease, hence registration of cases is done by active methods. The registry contributed survival data for 42 cancer sites or types registered during 1997-2001. The follow-up information has been obtained predominantly by passive methods, with median follow-up ranging between 1-44 months for various cancers. The proportion with histologically verified diagnosis for different cancers ranged between 16-100%; death certificates only (DCOs) comprised 0-51%; 49-100% of total registered cases were included for the survival analysis. The top-ranking cancers on 5-year age-standardized relative survival rates were testis (98%), thyroid (90%), ureter (87%), adrenal gland (86%), nonmelanoma skin (83%), corpus uteri (82%), Hodgkin lymphoma (81%), breast and cervix (74%). Five-year relative survival by age group showed a decreasing trend with increasing age groups for cancers of the stomach, small intestine, colon, gall bladder, larynx, lung, breast, cervix and ovary, and was fluctuating for other cancers.

AB - The Incheon cancer registry was established in 1997. Cancer is not a notifiable disease, hence registration of cases is done by active methods. The registry contributed survival data for 42 cancer sites or types registered during 1997-2001. The follow-up information has been obtained predominantly by passive methods, with median follow-up ranging between 1-44 months for various cancers. The proportion with histologically verified diagnosis for different cancers ranged between 16-100%; death certificates only (DCOs) comprised 0-51%; 49-100% of total registered cases were included for the survival analysis. The top-ranking cancers on 5-year age-standardized relative survival rates were testis (98%), thyroid (90%), ureter (87%), adrenal gland (86%), nonmelanoma skin (83%), corpus uteri (82%), Hodgkin lymphoma (81%), breast and cervix (74%). Five-year relative survival by age group showed a decreasing trend with increasing age groups for cancers of the stomach, small intestine, colon, gall bladder, larynx, lung, breast, cervix and ovary, and was fluctuating for other cancers.

UR - http://www.scopus.com/inward/record.url?scp=79959771784&partnerID=8YFLogxK

M3 - Article

SP - 163

EP - 169

JO - IARC scientific publications

JF - IARC scientific publications

SN - 0300-5038

IS - 162

ER -